(Q45423911)

English

Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Rui-hong Zeng

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Wei Gong

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Chang-fa Fan

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Yun-fei Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Xing-guo Mei

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

30 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

941-947

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Immunopathological mechanisms in respiratory syncytial virus disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Reduction of respiratory syncytial virus titer in the lungs of mice after intranasal immunization with a chimeric peptide consisting of a single CTL epitope linked to a fusion peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Co-immunization of BALB/c mice with recombinant immunogens containing G protein fragment and chimeric CTL epitope of respiratory syncytial virus induces enhanced cellular immunity and high level of antibody response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Protection of BALE/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Antigenic heterogeneity of the attachment protein of bovine respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Disease accompanying in utero viral infection. The role of maternal antibody in tissue injury after transplacental infection with lymphocytic choriomeningitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Synergistic effect of immunization with a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.064

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.08.064

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45423911&oldid=2076934097"